B.A., George Washington; J.D., Order of the Coif, University of Virginia. Richard F. Kingham is a senior counsel assigned to the Washington and London offices of Covington & Burling. He formerly managed the London office and now coordinates the firm-wide Pharmaceutical and Biotechnology Life Sciences Industry Group. Since joining the firm in 1973, he has concentrated on regulation of pharmaceuticals, medical devices, foods and related products. He has acted for numerous pharmaceutical and biotechnology companies and served as an adviser to trade associations such as the Pharmaceutical Research and Manufacturers of America (PhRMA), the Consumer Healthcare Products Association, the National Pharmaceutical Council and the European Federation of Pharmaceutical Industries and Associations.
He has been a member of committees of the National Academy of Medicine concerned with federal vaccine policy and the National Advisory Allergy and Infectious Diseases Council of the National Institutes of Health, and he served as a member of a World Health Organization committee concerned with communication of drug safety information. He served as a lecturer at the University of Virginia School of Law from 1977-1990, teaching seminars in administrative law and food and drug law, and he has lectured in the graduate program in pharmaceutical medicine of the Cardiff University and a similar program at King’s College London in the United Kingdom. He received his law degree in 1973 from the University of Virginia, where he served as articles editor of the law review and was elected to the Order of the Coif. He is a member of the District of Columbia Bar and a Registered Foreign Lawyer in England and Wales.
